PTC Therapeutics, Inc. - PE Ratio

The PE Ratio as of June 2026 (TTM) for PTC Therapeutics, Inc. (PTCT) is -31.09

According to PTC Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -31.09. This represents a change of -72.38% compared to the average of -112.58 of the last 4 quarters.

PTC Therapeutics, Inc. (PTCT) Historical PE Ratio (quarterly & annually)

How has PTCT PE Ratio performed in the past?

The mean historical PE Ratio of PTC Therapeutics, Inc. over the last ten years is -5.80. The current -31.09 PE Ratio has changed 53.47% with respect to the historical average. Over the past ten years (40 quarters), PTCT's PE Ratio was at its highest in in the December 2017 quarter at 139.00. The PE Ratio was at its lowest in in the March 2026 quarter at -500.96.

PTC Therapeutics, Inc. (PTCT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of PTC Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

PTC Therapeutics, Inc. (PTCT) Average PE Ratio

How has PTCT PE Ratio performed in the past?

The current PE Ratio of PTC Therapeutics, Inc. (PTCT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

PTC Therapeutics, Inc. (PTCT) PE Ratio vs. Peers

How is PTCT’s PE Ratio compared to its peers?

PTC Therapeutics, Inc.’s PE Ratio is less than Alkermes plc (48.38), less than Krystal Biotech, Inc. (44.91), less than Metsera, Inc. (-23.34), greater than Arrowhead Pharmaceuticals, Inc. (-38.23), less than TG Therapeutics, Inc. (16.74), less than Vaxcyte, Inc. (-7.47), less than Arcellx, Inc. (-28.27), less than Atrium Therapeutics, Inc. (-4.74), greater than Protagonist Therapeutics, Inc. (-62.63), less than Crinetics Pharmaceuticals, Inc. (-6.98),

Build a custom stock screener for PTC Therapeutics, Inc. (PTCT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like PTC Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

PTC Therapeutics, Inc. (PTCT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like PTC Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.